您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Propranolol HCl(AY64043,ICI45520,NCS91523)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Propranolol HCl(AY64043,ICI45520,NCS91523)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Propranolol HCl(AY64043,ICI45520,NCS91523)图片
CAS NO:318-98-9
规格:≥98%
包装与价格:
包装价格(元)
500mg电议
1g电议
2g电议
5g电议
10g电议
25g电议
50g电议

产品介绍
理化性质和储存条件
Molecular Weight (MW)295.8
FormulaC16H21NO2.HCl
CAS No.318-98-9
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO: 59 mg/mL (199.5 mM)
Water: 6 mg/mL (20.3 mM)
Ethanol: <1 mg/mL
Other info

Chemical Name: 1-Naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol hydrochloride

InChi Key: ZMRUPTIKESYGQW-UHFFFAOYSA-N

InChi Code: InChI=1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H

SMILES Code: OC(CNC(C)C)COC1=C2C=CC=CC2=CC=C1.[H]Cl

SynonymsAY-64043, ICI-45520, NCS-91523; AY 64043, ICI 45520, NCS 91523; AY64043, ICI45520, NCS91523;
实验参考方法
In Vitro

In vitro activity: Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM. Propranolol hydrochloride is used to control hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.

In VivoPropranolol hydrochloride (orally administration; 40 mg/kg; daily) significantly reduces the vessel diameter relative to the vehicle-treated implants, and increases the number of cells that expressed phosphorylated ERK1/2 within the IH Matrigel implant
Animal modelMouse model of IH (infantile hemangiomas) with HemSC cells
Formulation & Dosage40 mg/kg; oral
References[1]. Galandrin S, et al. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol Pharmacol. 2006 Nov;70(5):1575-84. Epub 2006 Aug 1

[2]. Briley M, et al. Evidence against beta-adrenoceptor blocking activity of diltiazem, a drug with calcium antagonist properties. Br J Pharmacol. 1980 Aug;69(4):669-73.

[3]. Al-Majed AA, et al. Propranolol. Profiles Drug Subst Excip Relat Methodol. 2017;42:287-338.

[4]. Munabi NC, et al. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation. Stem Cells Transl Med. 2016 Jan;5(1):45-55.